癌症患者不接受医疗建议:来自德国多中心研究的见解
相关实验视频
Updated: Jun 3, 2025

09:39
Assessing Specificity of Anticancer Drugs In Vitro
Published on: March 23, 2016
9.4K
Sarah Krieg1, Sven H Loosen2, Christoph Roderburg2
1Department of Inclusive Medicine, University Hospital Ostwestfalen-Lippe, Bielefeld University, 33617 Bielefeld, Germany.
Cancers
|January 11, 2025
概括
在癌症患者中,违背医疗建议 (DAMA) 的出院与人口统计数据有关,而不是疾病严重程度. 年轻和男性患者更有可能过早离开医院,这凸显了有针对性的支持的需要.
科学领域:
- 在瘤学瘤学.
- 医疗保健管理的管理
- 患者的治疗结果.
背景情况:
- 违背医疗建议 (DAMA) 的出院会对患者的护理连续性产生负面影响,增加再入院和死亡率.
- 癌症患者的DAMA患病率和因素,在这些情况下,治疗坚持是至关重要的,研究不足.
研究的目的:
- 在一大批住院癌症患者中调查DAMA的患病率和相关因素.
- 在瘤学环境中确定与DAMA相关的患者人口统计和临床特征.
主要方法:
- 德国36家医院 (2019-2023) 匿名数据的多中心,横截面分析.
- 包括51505名癌症患者.
- 多变量逻辑回归用于评估DAMA与年龄,性别,癌症类型,转移和并发症的关联.
主要成果:
- DAMA发生在0.9%的癌症患者住院时.
- 在唇癌,口腔癌,喉癌 (2.1%),喉癌 (2.0%) 和肝癌 (1.8%) 中观察到的DAMA率最高.
- 在年轻患者 (≤50岁) (OR: 1.73) 和男性 (OR: 1.46) 中,DAMA的发生频率明显高;远程转移没有显著的关联 (OR: 0.96).
结论:
- 癌症患者的DAMA主要与人口和社会因素有关,而不是疾病严重程度.
- 研究结果表明,需要制定应对心理社会和经济挑战的策略,特别是针对年轻人和男性癌症患者.
- 需要进一步的研究来完善对这些DAMA关联的理解和临床应用.
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328

